Irena Nekola

Irena Nekola

Auto-generated profile, based on publicly available information

Irena Nekola

Pliva Croatia TAPI R&D, 10000 Zagreb, Croatia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
MRMislav Runje
Mislav Runje
SBSandra Babic
Sandra Babic
EMErnest Meštrović
Ernest Meštrović
INIrena Nekola
Irena Nekola
ŽDŽeljka Dujmić-Vučinić
Željka Dujmić-Vučinić
NVNina Vojčić
Nina Vojčić

17 August 2015 in Organic Process Research & Development
Verified
Journal Article
Closed access
FJFranjo Jović
Franjo Jović
ASAna Sučec
Ana Sučec
INIrena Nekola
Irena Nekola
DČDražen Čavužić
Dražen Čavužić
EMEugen Marcelić
Eugen Marcelić
EMErnest Meštrović
Ernest Meštrović

15 March 2018 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
JMJosipa Matić
Josipa Matić
INIrena Nekola
Irena Nekola
Aleksandar VišnjevacAleksandar Višnjevac
Aleksandar Višnjevac
RKRenata Kobetić
Renata Kobetić
IMIrena Martin-Kleiner
Irena Martin-Kleiner
BŽBiserka Žinić
Biserka Žinić
A fast and efficient route for the introduction of a methylene bridged-amine (morpholinomethyl) functionality in the C5 position of the sulfonylated cytosine nucleobase has been developed. First, novel N1-sulfonylcytosine derivatives 3–6 were prepared by the condensation of silylated cytosine with selected sulfonyl chlorides. They were subsequently transformed to 5-morpholinomethyl-N1-sulfonylcytosine derivatives (8, 12–15) using microwave irradiation. As a result of cytosine ring opening in N1-tosylcytosine, depending on the reaction conditions, peculiar tosyl-urea derivative 9 has been isolated, which provided additional insight into the reaction pathway. The influence of the C5-substituent on the antiproliferative activity has been evaluated by performing the MTT test on U251, MCF-7 and MOLT-4 tumor cell-lines.